Paper · 30179110
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 29
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19760422 | The role of mean diffusivity (MD) as a predictive index of the response to chemotherapy in locally advanced breast cancer: a preliminary study. | Eur Radiol | 2010 | https://conductscience.org/library/papers/19760422 | PubMed |
| 2 | 17785706 | Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17785706 | PubMed |
| 3 | 21220595 | Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21220595 | PubMed |
| 4 | 23928243 | Breast magnetic resonance imaging for monitoring response to therapy. | Magn Reson Imaging Clin N Am | 2013 | https://conductscience.org/library/papers/23928243 | PubMed |
| 5 | 23652844 | Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. | Eur Radiol | 2013 | https://conductscience.org/library/papers/23652844 | PubMed |
| 6 | 25891905 | Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer. | Clin Breast Cancer | 2015 | https://conductscience.org/library/papers/25891905 | PubMed |
| 7 | 27406346 | Adaptive Randomization of Neratinib in Early Breast Cancer. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27406346 | PubMed |
| 8 | 22623692 | Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. | Radiology | 2012 | https://conductscience.org/library/papers/22623692 | PubMed |
| 9 | 26624971 | Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL. | Radiology | 2016 | https://conductscience.org/library/papers/26624971 | PubMed |
| 10 | 27192501 | Diffusion-Weighted Breast Magnetic Resonance Imaging: A Semiautomated Voxel Selection Technique Improves Interreader Reproducibility of Apparent Diffusion Coefficient Measurements. | J Comput Assist Tomogr | 2016 | https://conductscience.org/library/papers/27192501 | PubMed |
| 11 | 26284600 | Diffusion MRI with Semi-Automated Segmentation Can Serve as a Restricted Predictive Biomarker of the Therapeutic Response of Liver Metastasis. | Magn Reson Imaging | 2015 | https://conductscience.org/library/papers/26284600 | PubMed |
| 12 | 16465174 | Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. | Br J Cancer | 2006 | https://conductscience.org/library/papers/16465174 | PubMed |
| 13 | 21127880 | Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. | Eur Radiol | 2011 | https://conductscience.org/library/papers/21127880 | PubMed |
| 14 | 27690173 | Diffusion-weighted breast MRI: Clinical applications and emerging techniques. | J Magn Reson Imaging | 2017 | https://conductscience.org/library/papers/27690173 | PubMed |
| 15 | 20851939 | Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. | Radiology | 2010 | https://conductscience.org/library/papers/20851939 | PubMed |
| 16 | 3763909 | MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. | Radiology | 1986 | https://conductscience.org/library/papers/3763909 | PubMed |
| 17 | 25816249 | Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy. | PLoS One | 2015 | https://conductscience.org/library/papers/25816249 | PubMed |
| 18 | 11121466 | Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. | J Natl Cancer Inst | 2000 | https://conductscience.org/library/papers/11121466 | PubMed |
| 19 | 26825883 | Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. | Medicine (Baltimore) | 2016 | https://conductscience.org/library/papers/26825883 | PubMed |
| 20 | 27798751 | Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinations. | Eur Radiol | 2017 | https://conductscience.org/library/papers/27798751 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/30179110/references